Forum: Pharming » Ruconest™ = geschiedenis, laten we ons nu focussen op :

Met IEX wordt u een betere belegger en verhoogt u het rendement op uw beleggingen

Vanaf 13,95 per maand leest u dagelijks onze professionele aandelenanalyses en kooptips.

Krijg toegang tot vele voordelen

Onbeperkt toegang tot onze Premium-content
Ons magazine IEX Expert (digitaal of papier)
Toegang tot onze 3 modelportefeuilles

Profiteer van de IEX producten

3 Modelportefeuilles
Dividendkalender
Aandelenselector

Aandeel Pharming Group AEX:PHARM.NL, NL0010391025

Laatste koers (eur) 0,881 19 apr 2024 17:35

Verschil +0,013 (+1,50%) Dagrange 0,869 - 0,889

Volume 8.926.686 Gem. (3M) 6,9M

Berdientje 2 augustus 2014 08:12

RhC1INH for organ transplants
There is significant scientific evidence that recombinant human C1 inhibitor (rhC1INH) can be used to prevent complications after organ transplantation.

Medical need
Despite all the technical advances that have been made during the last decades, rejection of transplanted organs remains a critical issue. Given the shortage of available organs and the high costs associated with transplantation, there is a need for additional new and safe products that reduce the chances of organ rejection. The C1 inhibitor protein may play a significant role in preventing problems after solid organ transplantation, such as delayed graft function and antibody-mediated rejection. C1INH reduces the inflammatory reactions that lead to tissue damage, malfunctioning and sometimes a rejection of the transplanted organ.

Pharming’s therapy
There is significant scientific evidence that our product recombinant human C1 inhibitor can be used as a safe and effective treatment to prevent complications after organ transplantation. Our technology enables for the quality-controlled large-scale production and purification of the protein, yielding a safe product.

Pharming's lactoferrin product
Pharming is focusing on the development of human lactoferrin (hLF) for use as an ingredient in advanced nutritional products. The product also has potential for pharmaceutical applications (e.g. against systemic infections).

Food and food supplements
Lactoferrin is a protein naturally occurring in many human secretions including mother’s milk, saliva and tears. The protein has unique anti-infective and anti-inflammatory properties and it plays an important role in the defense system of infants as well as adults, where it is active against a wide range of bacterial, fungal and viral pathogens.

Pharming food additives
The first commercial application of hLF is the use as an ingredient in foods and food supplements, targeted at people who will benefit from the use of hLF.

Direct naar Forum

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Beurscodes, betekenis en hulp bij zoeken

Europa

Noord-Amerika

Kunt u een instrument niet vinden?

Waar vind ik die ISIN code?

Inloggen

Met IEX wordt u een betere belegger en verhoogt u het rendement op uw beleggingen

Krijg toegang tot vele voordelen

Profiteer van de IEX producten

Nederland

Europa

Amerika

Aandeel Pharming Group AEX:PHARM.NL, NL0010391025

Melding

Ruconest™ = geschiedenis, laten we ons nu focussen op :

Berdientje

Aanbevelingen

Aantal posts: 7.777

Meedoen aan de discussie?

Direct naar Forum

Logische herfinanciering Pharming

Pharming Nieuws

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links

Hét Warren Buffett-pakket al aangevraagd?

Pearl Capital: beleggen met zekerheid

Nederlandse MKB Participatiemaatschappij

Bitvavo

Meld u aan voor de dagelijkse Beursupdate

Verzoek